Lv1
48 积分 2022-11-29 加入
In vivo engineering of CAR natural killer cells for immunotherapy using ligand-directed lipid nanoparticles
7天前
已完结
Depletion of an immature cord blood NK subset reverses trogocytosis-driven CAR NK dysfunction
2个月前
已关闭
Depletion of an immature cord blood NK subset reverses trogocytosis-driven CAR NK dysfunction
2个月前
已关闭
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial
2个月前
已完结
Programmable iPSC-derived CAR-NK vesicles remodel the immune microenvironment and eradicate tumors
6个月前
已完结
Abstract LB313: Advancing iPSC derived CAR NK cell therapy for enhanced solid tumor treatment
6个月前
已完结
OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours
6个月前
已完结
TIM3 Blockade in Dendritic Cells May Potentiate Antitumor Immunity
7个月前
已完结
Pluripotent stem cell-derived CAR-NK progenitor therapy targets minimal residual disease and prevents relapse in leukemia models
8个月前
已完结
Pluripotent stem cell-derived CAR-NK progenitor therapy targets minimal residual disease and prevents relapse in leukemia models
8个月前
已完结